SCHEMBL4628348

SCHEMBL4628348

Cc1cc(C)c(C)c(Cc2c[nH]c(-c3nc(Cc4ccccc4)c[nH]3)n2)c1C

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.40
GABRB2 P47870 2/20 0.40
POLB P06746 2/20 0.39
KDM4E B2RXH2 4/20 0.37
HSD17B10 Q99714 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HTT P42858 1/20 0.37
TAAR1 Q96RJ0 1/20 0.34
ADORA2A P29274 2/20 0.34
ADORA1 P30542 2/20 0.34
TSHR P16473 1/20 0.34
NPC1 O15118 1/20 0.34
KMT2A Q03164 1/20 0.34
HPGD P15428 2/20 0.33
APAF1 O14727 1/20 0.33
TP53 P04637 1/20 0.33
HTR2B P41595 1/20 0.33
BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4629511 0.85 TAAR1 (0.40) GABRA1GABRB2POLBKDM4EHSD17B10
SCHEMBL4628344 0.77 GABRA1 (0.35) GABRA1GABRB2POLBKDM4EHSD17B10
SCHEMBL7923371 0.76 CALM1 (0.48) POLBKDM4EALDH1A1HPGDTP53
SCHEMBL17622 0.75 CXCR2 (0.42) GABRA1GABRB2POLBKDM4EHSD17B10
SCHEMBL17279789 0.74 SMN1; SMN2 (0.42) GABRA1GABRB2POLBKDM4EHSD17B10
Hydrochloric Acid SCHEMBL8588873 0.73 CXCR2 (0.41) GABRA1GABRB2POLBKDM4EHSD17B10
SCHEMBL82538 0.73 TAAR1 (0.43) GABRA1GABRB2POLBSMN1; SMN2ALDH1A1
SCHEMBL28856048 0.72 CCR1 (0.43) GABRA1GABRB2POLBKDM4EHSD17B10
SCHEMBL3844900 0.72 GABRA1 (0.48) GABRA1GABRB2POLBKDM4EHSD17B10
SCHEMBL9371816 0.72 TAAR1 (0.51) POLBKDM4ESMN1; SMN2ALDH1A1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1981880-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2008-10-22 EP disclosed
WO-2007085556-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-02 WO disclosed